Liu et al. (22) reported that scrg1 was upregulated in osteoarthritis synovitis and was correlated with increased immune response; thus, scrg1 has been identified as a potential therapeutic target for human synovial inflammation. This evidence concerns the gene SCRG1 and osteoarthritis.